Thomas Björk
Impact in
-
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Lung Cancer Treatments and Mutations
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
Papers in
-
- Prostate Cancer Diagnosis and Treatment 19
- Prostate Cancer Treatment and Research 8
- Urology 4
- Urinary Bladder and Prostate Research 4
- Co-authors
- Hans G. Lilja (21 shared papers)Per‐Anders Abrahamsson (6 shared papers)David H. Ulmert (9 shared papers)Abraham T.�K. Cockett (2 shared papers)Andrew Julian Vickers (9 shared papers)Anders G. Christensson (3 shared papers)Anders S Bjartell (5 shared papers)Marja‐Terttu Matikainen (1 shared paper)
- Journals
- The Journal of Urology (6 papers)Urology (4 papers)Journal of Clinical Oncology (3 papers)The Prostate (3 papers)European Journal of Clinical Microbiology & Infectious Diseases (2 papers)
- Partner nations
- SwedenUnited StatesFinland
In The Last Decade
Thomas Björk
33 papers receiving 2.8k citations
Thomas Björk's Hit Papers
Peers
Comparison fields: 5 of 98
- Pulmonary and Respiratory Medicine 2.0k
- Oncology 642
- Urology 92
- Cancer Research 215
- Rheumatology 177
Countries citing papers authored by Thomas Björk
This map shows the geographic impact of Thomas Björk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Björk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Björk more than expected).
Fields of papers citing papers by Thomas Björk
This network shows the impact of papers produced by Thomas Björk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Björk. The network helps show where Thomas Björk may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Björk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase I Safety, Pharmacokinetic, and Pharmacodynamic Trial of ZD1839, a Selective Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Five Selected Solid Tumor Types Hit paper breakdown → | 2002 | 732 |
| 2 | Serum Prostate Specific Antigen Complexed toα1-Antichymotrypsin as an Indicator of Prostate Cancer Hit paper breakdown → | 1993 | 560 |
| 3 | 2013 | 213 | |
| 4 | 2010 | 178 | |
| 5 | 2012 | 157 | |
| 6 | 2007 | 154 | |
| 7 | 1994 | 118 | |
| 8 | 2008 | 94 | |
| 9 | 2008 | 91 | |
| 10 | 1993 | 75 | |
| 11 | 2000 | 70 | |
| 12 | 1998 | 67 | |
| 13 | 1987 | 62 | |
| 14 | 1996 | 61 | |
| 15 | 2005 | 59 | |
| 16 | 2005 | 43 | |
| 17 | Improvements in quality of life and disease-related symptoms in phase I trials of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in non-small cell lung cancer and other solid tumors. | 2003 | 42 |
| 18 | 1999 | 41 | |
| 19 | 1986 | 38 | |
| 20 | 2007 | 35 |
About Thomas Björk
Thomas Björk is a scholar working on Pulmonary and Respiratory Medicine, Urology, Rheumatology, Finance and Epidemiology, having authored 34 papers that have together received 3.0k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (19 papers), Prostate Cancer Treatment and Research (8 papers), Urinary Bladder and Prostate Research (4 papers), Urinary Tract Infections Management (4 papers), Urologic and reproductive health conditions (2 papers), Hormonal and reproductive studies (2 papers), Bladder and Urothelial Cancer Treatments (2 papers) and Pediatric Urology and Nephrology Studies (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.0k citations), Oncology (642 citations), Urology (92 citations), Cancer Research (215 citations) and Rheumatology (177 citations). Thomas Björk has collaborated with scholars based in Sweden, United States and Finland. Frequent co-authors include Hans G. Lilja, Per‐Anders Abrahamsson, David H. Ulmert, Abraham T.�K. Cockett, Andrew Julian Vickers, Anders G. Christensson, Anders S Bjartell, Marja‐Terttu Matikainen, Olle Nilsson and Peter T. Scardino. Their work appears in journals such as The Journal of Urology, Urology, Journal of Clinical Oncology, The Prostate and European Journal of Clinical Microbiology & Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.